Zhongnan Hospital of Wuhan University — Wuhan, Hubei

Public research footprint of Zhongnan Hospital of Wuhan University, compiled from the ClinicalTrials.gov public registry.

315

Registered studies

153

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Non-Small Cell Lung Cancer · Breast Cancer · High Grade Glioma (III or IV) · Chronic Thromboembolic Pulmonary Hypertension (CTEPH)

Recently updated registry entries

NCT07741448 — Neoadjuvant Gemcitabine Plus Trastuzumab Rezetecan in HER2-positive UTUC (Recruiting)
NCT05461768 — A Study of BL-M07D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Low… (Recruiting)
NCT07741578 — Sequential Order of RSI on Tracheal Intubation (Completed)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Zhongnan Hospital of Wuhan University?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.